Birdwatch Note
2024-07-16 07:12:56 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
国内で承認されたレプリコンワクチンが世界初の自己増殖型のワクチンというのは誤情報でインドではそれに先立ってGemcovac-19が承認を受けています。 ニュース https://www.forbes.com/sites/williamhaseltine/2022/10/14/self-amplifying-mrna-vaccine-receives-eua-nod-from-indian-regulators/ wiki https://en.wikipedia.org/wiki/COVID-19_vaccine
Written by 41A6243EF0C5E2F69F5A0D4006A468F4F7CBEC237CAE6ACCC5FB56ED687492FE
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1813039225844953432
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1813109544496820599
- noteId - 1813109544496820599
- participantId -
- noteAuthorParticipantId - 41A6243EF0C5E2F69F5A0D4006A468F4F7CBEC237CAE6ACCC5FB56ED687492FE Participant Details
- createdAtMillis - 1721113976012
- tweetId - 1813039225844953432
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 国内で承認されたレプリコンワクチンが世界初の自己増殖型のワクチンというのは誤情報でインドではそれに先立ってGemcovac-19が承認を受けています。 ニュース https://www.forbes.com/sites/williamhaseltine/2022/10/14/self-amplifying-mrna-vaccine-receives-eua-nod-from-indian-regulators/ wiki https://en.wikipedia.org/wiki/COVID-19_vaccine
Note Ratings
rated at | rated by | |
2024-08-22 22:05:15 -0500 | Rating Details | |
2024-08-18 08:04:06 -0500 | Rating Details | |
2024-08-18 02:58:14 -0500 | Rating Details | |
2024-09-26 01:34:58 -0500 | Rating Details | |
2024-09-19 21:48:36 -0500 | Rating Details | |
2024-09-07 16:22:44 -0500 | Rating Details | |
2024-10-03 03:06:26 -0500 | Rating Details |